CERF helps control meningitis outbreak in Burkina Faso
11 April 2007: CERF allocates USD 1.8 million to control a meningitis outbreak in Burkina Faso.
A meningitis epidemic has erupted in Burkina Faso, while eight other West African countries have been affected by the highly contagious disease to varying degrees. Since 1 January 2007, Burkina Faso alone has registered over 15,000 cases and 1,100 deaths according to WHO. Particular concern is raised that the current trend of the epidemic could be similar to the situation in 1996, where nearly 43,000 cases led to a death toll above 4,300 in Burkina Faso alone.
Like other countries in the meningitis belt spanning from Senegal to Ethiopia, Burkina Faso has a history of meningitis epidemics. Between 1995 and 1997 the meningitis belt experienced the largest recent epidemic, with over 250,000 cases and 25,000 deaths registered. A worst case scenario would involve a generalization of the epidemic in the meningitis belt and the lack of sufficient doses of vaccines to protect people at risk. Weak health infrastructures would quickly become overwhelmed and some 30,000 human lives could potentially be at risk.
![Meningitis Belt 1995-1999 [Source: WHO]](/Portals/11/Images_country/CDI_WHO_MeningitisBelt_crop.jpg) |
|
Meningitis Belt 1995-1999 [Source: WHO]
|
However, this year, the epidemic has expanded rapidly in comparison with the same period last year. The Government of Burkina Faso appealed for international assistance on 23 February and a range of health partners with local presence in Burkina came forward with immediate assistance. As of early April, in spite of the many efforts already undertaken, the Government and health partners are faced with a situation where the epidemic continues to expand. 41 health districts out of 55, with a total population of over 10 million persons, are considered to be in a state of epidemic according to the Ministry of Health.
The CERF grant of $1 million is enabling UNICEF to ensure the supply of vaccines for a mass campaign over a three months period. WHO will use its allocation of $800,000 for logistics that serve the implementation of the vaccination campaign. The aim is to reduce morbidity and mortality among the population at risk.
Elsewhere in the sub-region, an allocation of $1.7 million from the Central Emergency Response Fund (CERF) has been made available to fight the meningitis outbreak in northern Côte d’Ivoire.
What is meningitis?
The cause of meningitis is the Bacterium Neisseria meningitidis. Strains A, B, C, Y, and W135 are the most common. Infected people typically carry the disease without showing symptoms and spread the bacteria through coughing and sneezing. Meningitis causes sudden and intense headaches, fever, nausea, vomiting, photophobia, and stiffness of the neck. Death may occur within hours of the onset of symptoms. The disease occurs sporadically throughout the world, but the vast majority of cases and deaths are in Africa. Epidemics regularly hit countries in the area referred to as the African "meningitis belt," which stretches across the continent from Senegal to Ethiopia. The total population at risk in these countries is around 300 million.
Without treatment, bacterial meningitis kills up to 50 percent of infected people. Even if the disease is diagnosed early and treated with appropriate antibiotics, such as chloramphenicol or ceftriaxone, the case fatality rate remains 5 to 10 percent. As many as one out of five survivors will suffer from neurological after-effects such as deafness or mental retardation. Timely mass vaccinations are the most effective means of limiting the spread of epidemics. The World Health Organization (WHO) has estimated that mass immunizations have managed to prevent up to 70 percent of expected cases in individual meningitis outbreaks in Africa.
[Last update: 12 April 2007]
«CERF Around the World